VALIANT LABORATORIES
Back to Income Statement
|
VALIANT LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Sales | ₹237 Cr | ₹133 Cr | ₹182 Cr | ₹334 Cr |
What is the latest Revenue of VALIANT LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹237 Cr |
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹182 Cr |
| Mar2023 | ₹334 Cr |
How is Revenue of VALIANT LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹237 Cr | 78.04 | |
| Mar2025 | ₹133 Cr | -26.74 | |
| Mar2024 | ₹182 Cr | -45.48 | |
| Mar2023 | ₹334 Cr | - | |
Compare Revenue of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹538.7 Cr | -7.7% | -29.7% | 26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -7.7% |
-29.7% |
26.5% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses